In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up.
To determine the optimum duration of follow-up for the assessment of drug efficacy against Plasmodium falciparum malaria, 96 trial arms from randomized controlled trials (RCTs) with follow-up of 28 days or longer that were conducted between 1990 and 2003 were analyzed. These trials enrolled 13,772 p...
主要な著者: | Stepniewska, K, Taylor, W, Mayxay, M, Price, R, Smithuis, F, Guthmann, J, Barnes, K, Myint, H, Adjuik, M, Olliaro, P, Pukrittayakamee, S, Looareesuwan, S, Hien, T, Farrar, J, Nosten, F, Day, N, White, N |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2004
|
類似資料
-
Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria.
著者:: Mayxay, M, 等
出版事項: (2001) -
The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria.
著者:: Lee, S, 等
出版事項: (2008) -
Genetic analysis of Plasmodium falciparum infections on the north-western border of Thailand.
著者:: Paul, R, 等
出版事項: (1999) -
Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis
著者:: Dahal, P, 等
出版事項: (2022) -
The relationship between the haemoglobin concentration and the haematocrit in <it>Plasmodium falciparum </it>malaria
著者:: Newton Paul, 等
出版事項: (2008-08-01)